Compare NNNN & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | ARI |
|---|---|---|
| Founded | 2021 | 2009 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | N/A | 2009 |
| Metric | NNNN | ARI |
|---|---|---|
| Price | $23.79 | $10.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 26.3K | ★ 1.2M |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 9.40% |
| EPS Growth | N/A | ★ 183.51 |
| EPS | N/A | ★ 0.81 |
| Revenue | N/A | ★ $271,589,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $446.57 | ★ $13.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.91 | $7.70 |
| 52 Week High | $55.65 | $11.21 |
| Indicator | NNNN | ARI |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | 48.17 |
| Support Level | $19.53 | $9.60 |
| Resistance Level | $30.70 | $10.95 |
| Average True Range (ATR) | 1.97 | 0.21 |
| MACD | 0.41 | 0.01 |
| Stochastic Oscillator | 84.48 | 54.62 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.